COR Q2 2018 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$68B

Q2 2018 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$41.0B+10.5% YoY

Gross Profit

$1.1B2.8% margin

Operating Income

$519M1.3% margin

Net Income

$287M0.7% margin

EPS (Diluted)

$1.29

QoQ Revenue Growth

+1.4%

Cash Flow

Operating Cash Flow

-$88M

Free Cash Flow

-$183M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$38.4B

Total Liabilities

$35.0B

Stockholders' Equity

$3.2B

Cash & Equivalents

$2.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41.0B	$37.1B	+10.5%
Gross Profit	$1.1B	$1.2B	-2.0%
Operating Income	$519M	$637M	-18.6%
Net Income	$287M	$411M	-30.1%

Revenue Segments

Pharmaceutical Distribution

$39.5B96%

Other Segments

$1.6B4%

Geographic Segments

Other Segments

$1.6B100%